CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic growth hormone-releasing hormone (GHRH) analog widely studied for its ability to support sustained growth hormone release and endocrine function. The addition of the Drug Affinity Complex (DAC) significantly extends the peptide’s half-life, allowing for prolonged biological activity and making it an important compound in research focused on growth hormone physiology, metabolism, and tissue regeneration.
Researchers investigate CJC-1295 with DAC for its potential role in promoting the natural secretion of growth hormone, supporting protein synthesis, lean muscle development, tissue repair, and cellular regeneration. It is also commonly studied for its influence on fat metabolism, recovery mechanisms, exercise physiology, and healthy aging. By enhancing endogenous growth hormone signaling over an extended period, CJC-1295 with DAC provides valuable insight into the regulation of anabolic and metabolic processes.
CJC-1295 with DAC continues to be an important research peptide in studies involving endocrine science, regenerative medicine, muscle physiology, body composition, and long-term growth hormone regulation.
Reviews
There are no reviews yet.